• A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany Italy
  • A study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France The Netherlands Spain
  • Comparing ziconotide and a drug combination to standard medical management for patients with severe cancer pain

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • A study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    Belgium France Germany Italy The Netherlands Spain
  • A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa

    Recruiting

    2 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Spain +1
  • A study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease

    Recruiting

    2 1 1 1
    Italy Spain
  • Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

    Recruiting

    3 1 1
    Belgium Czechia France Germany Italy The Netherlands +2
  • Study of the safety and use of the Extroducer infusion catheter system for delivering gemcitabine to patients with unresectable locally advanced pancreatic cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • A study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis

    Recruiting

    3 1 1
    Investigated Drugs:
    Sweden
  • A study to evaluate the effectiveness and safety of ursodeoxycholic acid in patients with hepatorenal polycystic diseases.

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

powered by